Prothena Corp. (NASDAQ: PRTA) reported Q4 EPS of ($1.26), $0.08 worse than the analyst estimate of ($1.18). Revenue for the quarter came in at $316 million versus the consensus estimate of $2.15 million.

For earnings history and earnings-related data on Prothena Corp. (PRTA) click here.